WCM
Wedge Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-239,868
| Closed | -$29.8M | – | 525 |
|
|
2025
Q1 | $29.8M | Sell |
239,868
-3,137
| -1% | -$389K | 0.58% | 81 |
|
|
2024
Q4 | $29.9M | Sell |
243,005
-48,679
| -17% | -$5.99M | 0.54% | 64 |
|
|
2024
Q3 | $32.5M | Buy |
+291,684
| New | +$32.5M | 0.56% | 68 |
|
|
2024
Q1 | – | Sell |
-243,357
| Closed | -$29.9M | – | 509 |
|
|
2023
Q4 | $29.9M | Buy |
243,357
+20,587
| +9% | +$2.53M | 0.53% | 66 |
|
|
2023
Q3 | $28.8M | Sell |
222,770
-16,312
| -7% | -$2.11M | 0.57% | 73 |
|
|
2023
Q2 | $29.6M | Sell |
239,082
-33,786
| -12% | -$4.19M | 0.47% | 73 |
|
|
2023
Q1 | $39.9M | Buy |
272,868
+18,379
| +7% | +$2.69M | 0.67% | 23 |
|
|
2022
Q4 | $40.5M | Buy |
254,489
+12,524
| +5% | +$2M | 0.65% | 27 |
|
|
2022
Q3 | $32.3M | Buy |
241,965
+1,343
| +0.6% | +$179K | 0.55% | 77 |
|
|
2022
Q2 | $37.5M | Buy |
+240,622
| New | +$37.5M | 0.6% | 49 |
|
|
2021
Q1 | – | Sell |
-180,075
| Closed | -$29.7M | – | 560 |
|
|
2020
Q4 | $29.7M | Sell |
180,075
-14,950
| -8% | -$2.47M | 0.34% | 92 |
|
|
2020
Q3 | $27.8M | Buy |
+195,025
| New | +$27.8M | 0.37% | 82 |
|
|
2020
Q1 | – | Sell |
-288,973
| Closed | -$43.1M | – | 557 |
|
|
2019
Q4 | $43.1M | Buy |
288,973
+12,960
| +5% | +$1.93M | 0.48% | 70 |
|
|
2019
Q3 | $35.4M | Buy |
276,013
+20,553
| +8% | +$2.63M | 0.41% | 82 |
|
|
2019
Q2 | $36.4M | Sell |
255,460
-30,981
| -11% | -$4.42M | 0.42% | 81 |
|
|
2019
Q1 | $40.9M | Buy |
+286,441
| New | +$40.9M | 0.47% | 64 |
|